MedTrace Logo

Novel Rapid POC Diagnostics for COVID-19

NCT05438589 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1283

Last updated 2023-12-01

No results posted yet for this study

Summary

This is a prospective, multicentre study in which the diagnostic accuracy of multiple Covid-19 Antigen rapid diagnostic tests will be assessed for COVID-19 case detection using prospectively collected nasal swabs and saliva samples from participants suspected to have Covid-19 infection (with or without symptoms). The study will last approximately 9 months.

Conditions

  • COVID-19 Respiratory Infection

Sponsors & Collaborators

  • Foundation for Innovative New Diagnostics, Switzerland

    lead OTHER

Principal Investigators

  • Elena Ivanova Reipold, MD, PhD · Find

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-04-25
Primary Completion
2023-02-28
Completion
2023-02-28

Countries

  • Georgia
  • South Africa

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05438589 on ClinicalTrials.gov